165 related articles for article (PubMed ID: 36644997)
1. Circular RNA SPI1 expression before and after induction therapy and its correlation with clinical features, treatment response, and survival of acute myeloid leukemia patients.
Xiong T; Xia L; Song Q
J Clin Lab Anal; 2023 Feb; 37(3):e24835. PubMed ID: 36644997
[TBL] [Abstract][Full Text] [Related]
2. The role of circular RNA plasmacytoma variant translocation 1 as a biomarker for prognostication of acute myeloid leukemia.
Chen T; Chen F
Hematology; 2021 Dec; 26(1):1018-1024. PubMed ID: 34871521
[TBL] [Abstract][Full Text] [Related]
3. Screening and validating circular RNAs that estimate disease risk and treatment response of pediatric acute myeloid leukemia: a microarray-based analyses and RT-qPCR validation.
Ye F; Fan C; Peng M; Liu S; Dong J; Yang L; Zhang H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11233-11245. PubMed ID: 37358666
[TBL] [Abstract][Full Text] [Related]
4. SETD2 detection may reveal response to induction therapy and survival profile in acute myeloid leukemia patients.
Liu H
Hematology; 2023 Dec; 28(1):2161194. PubMed ID: 36607144
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA of vimentin expression as a valuable predictor for acute myeloid leukemia development and prognosis.
Yi YY; Yi J; Zhu X; Zhang J; Zhou J; Tang X; Lin J; Wang P; Deng ZQ
J Cell Physiol; 2019 Apr; 234(4):3711-3719. PubMed ID: 30152863
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_0044907 promotes acute myeloid leukemia progression through upregulating oncogene KIT via sequestering miR-186-5p.
Liu L; Qiang X
Hematology; 2022 Dec; 27(1):960-970. PubMed ID: 36004511
[TBL] [Abstract][Full Text] [Related]
7. [Expression of circ-KEL in acute myeloid leukemia and its regulatory mechanisms in leukemic cells].
Wu ZJ; Sun Q; Gu DL; Wang LQ; Li JY; Jin H
Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):230-237. PubMed ID: 33910309
[No Abstract] [Full Text] [Related]
8. Potentiality of Protein phosphatase Mg
Yu M; Hu J; He D; Chen Q; Liu S; Zhu X; Li B
J Clin Lab Anal; 2020 May; 34(5):e23171. PubMed ID: 31901183
[TBL] [Abstract][Full Text] [Related]
9. The clinical and prognostic significance of FIS1, SPI1, PDCD7 and Ang2 expression levels in acute myeloid leukemia.
Abo Elwafa R; Gamaleldin M; Ghallab O
Cancer Genet; 2019 Apr; 233-234():84-95. PubMed ID: 30555023
[TBL] [Abstract][Full Text] [Related]
10. Serum hsa_circ_0079480 is a novel prognostic marker for acute myeloid leukemia.
Guo L; Kou R; Song Y; Li G; Jia X; Li Z; Zhang Y
J Clin Lab Anal; 2022 Apr; 36(4):e24337. PubMed ID: 35297094
[TBL] [Abstract][Full Text] [Related]
11. CircSPI1 acts as an oncogene in acute myeloid leukemia through antagonizing SPI1 and interacting with microRNAs.
Wang X; Jin P; Zhang Y; Wang K
Cell Death Dis; 2021 Mar; 12(4):297. PubMed ID: 33741901
[TBL] [Abstract][Full Text] [Related]
12. SUMO specific peptidase 1 decreases after induction treatment, and its reduction predicts lower disease risk, better treatment response, longer survival of acute myeloid leukemia.
Liu J; Li Y; Zhang G
Scand J Clin Lab Invest; 2023 Sep; 83(5):283-289. PubMed ID: 37405376
[TBL] [Abstract][Full Text] [Related]
13. Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients.
Zhou J; Zhou LY; Tang X; Zhang J; Zhai LL; Yi YY; Yi J; Lin J; Qian J; Deng ZQ
BMC Cancer; 2019 Sep; 19(1):930. PubMed ID: 31533653
[TBL] [Abstract][Full Text] [Related]
14. Blood MALT1 deficiency is common and relates to unfavorable induction therapy response and survival profile in acute myeloid leukemia patients.
Geng H; Wang Y; Wang S
Hematology; 2022 Dec; 27(1):1176-1183. PubMed ID: 36314929
[TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0002483 regulates miR-758-3p/MYC axis to promote acute myeloid leukemia progression.
Xiao Y; Ming X; Wu J
Hematol Oncol; 2021 Apr; 39(2):243-253. PubMed ID: 33283885
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA profile of acute myeloid leukaemia indicates circular RNA annexin A2 as a potential biomarker and therapeutic target for acute myeloid leukaemia.
Ding Y; Dong Y; Lu H; Luo X; Fu J; Xiu B; Liang A; Zhang W
Am J Transl Res; 2020; 12(5):1683-1699. PubMed ID: 32509169
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA circ_0040823 inhibits the proliferation of acute myeloid leukemia cells and induces apoptosis by regulating miR-516b/PTEN.
Wang N; Yang B; Jin J; He Y; Wu X; Yang Y; Zhou W; He Z
J Gene Med; 2022 Mar; 24(3):e3404. PubMed ID: 34913223
[TBL] [Abstract][Full Text] [Related]
18. The quantification of circular RNA 0007841 during induction therapy helps estimate the response and survival benefits to bortezomib-based regimen in multiple myeloma.
Guo Y; Feng X; Wang Z; Zhang R; Zheng K; Xu J; Hu P; Zhang R
Ir J Med Sci; 2024 Feb; 193(1):17-25. PubMed ID: 37336827
[TBL] [Abstract][Full Text] [Related]
19. IncRNA MVIH correlates with disease features, predicts treatment response and survival in pediatric acute myeloid leukemia.
Xue H; Gao H; Xia H; Li S; Li N; Gao C; Duan Y; Ren Y; Zhang H; Liu J; Gao W
J Clin Lab Anal; 2021 Apr; 35(4):e23739. PubMed ID: 33704838
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA_0000190 and its target microRNA-767-5p are dysregulated, and they are related to risk stratification as well as prognosis in multiple myeloma patients.
Xiang Y; Xu X; Yang B; Wu Z; Jiang R; Xie Y
Ir J Med Sci; 2022 Apr; 191(2):671-679. PubMed ID: 33864191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
